-
RBC Capital on Ideaya Biosciences (IDYA): 'R&D Day Underscores Strengths & Expansive Pipeline'
-
RBC Capital Reiterates Outperform Rating on Ideaya Biosciences (IDYA)
-
IDEAYA Announces Closing of Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares
-
Ideaya Biosciences (IDYA) PT Raised to $61 at RBC Capital
-
IDEAYA Biosciences (IDYA) Prices 7.23M Share Offering at $35/sh
-
IDEAYA Announces Pricing of Public Offering
-
2Q24 U.S. biotech earnings preview
-
IDEAYA Biosciences (IDYA) Announces Proposed $200M Share and Warrant Offering
-
IDEAYA Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
-
IDEAYA Biosciences to Participate in Upcoming May 2024 Investor Relations Event
-
IDEAYA Announces Closing of Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares
-
IDEAYA Biosciences (IDYA) Prices 5M Share Offering at $23.50/sh
-
IDEAYA Announces Pricing of Public Offering
-
IDEAYA Biosciences (IDYA) Announces Proposed $125M Share and Warrant Offering
-
IDEAYA Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
-
IDEAYA Biosciences to Participate in Upcoming May 2023 Investor Relations Event
-
IDEAYA Announces Closing of Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares
-
IDEAYA Biosciences (IDYA) Prices 7.44M Share Offering at $18.50/sh
-
IDEAYA Announces Pricing of Public Offering

